您的购物车当前为空
别名 5,7-二羟基-6,8-二异戊烯基色原酮, 5,7-Dihydroxy-6,8-diprenylchromone
Eriosemation significant androgen receptor (AR) inhibition activity, suggests that it could be a promising candidate for further evaluation for prostate cancer prevention or management.

Eriosemation significant androgen receptor (AR) inhibition activity, suggests that it could be a promising candidate for further evaluation for prostate cancer prevention or management.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 3,710 | 待询 |
| 产品描述 | Eriosemation significant androgen receptor (AR) inhibition activity, suggests that it could be a promising candidate for further evaluation for prostate cancer prevention or management. |
| 别名 | 5,7-二羟基-6,8-二异戊烯基色原酮, 5,7-Dihydroxy-6,8-diprenylchromone |
| 分子量 | 314.38 |
| 分子式 | C19H22O4 |
| CAS No. | 162616-72-0 |
| 密度 | 1.184 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容